Cormedix
Clinical trials sponsored by Cormedix, explained in plain language.
-
New drug aims to cut deadly infections in patients on home IV nutrition
Disease control Recruiting nowThis study tests whether a drug called DefenCath can prevent serious bloodstream infections in adults who receive nutrition through a central line at home. About 200 participants will be randomly assigned to receive either DefenCath or a standard heparin solution as a catheter lo…
Phase: PHASE3 • Sponsor: CorMedix • Aim: Disease control
Last updated May 17, 2026 08:25 UTC
-
New hope for kids on dialysis: drug-filled catheter may stop deadly infections
Prevention Recruiting nowThis study tests a drug called DefenCath in children from birth to under 18 years old who have kidney failure and need dialysis through a tube (catheter). The goal is to see if DefenCath can prevent serious bloodstream infections better than the usual care. About 36 children will…
Phase: PHASE4 • Sponsor: CorMedix • Aim: Prevention
Last updated May 12, 2026 13:40 UTC